- Home
- MLYS vs SSYS Comparison
MLYS vs SSYS Comparison
Compare MLYS & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- SSYS
- Stock Information
- Founded
- MLYS 2019
- SSYS 1989
- Country
- MLYS United States
- SSYS United States
- Employees
- MLYS N/A
- SSYS N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- MLYS Health Care
- SSYS Technology
- Exchange
- MLYS Nasdaq
- SSYS Nasdaq
- Market Cap
- MLYS 893.0M
- SSYS 728.4M
- IPO Year
- MLYS 2023
- SSYS 1994
- Fundamental
- Price
- MLYS $15.14
- SSYS $11.24
- Analyst Decision
- MLYS Strong Buy
- SSYS Strong Buy
- Analyst Count
- MLYS 3
- SSYS 4
- Target Price
- MLYS $33.00
- SSYS $12.50
- AVG Volume (30 Days)
- MLYS 679.3K
- SSYS 476.1K
- Earning Date
- MLYS 05-12-2025
- SSYS 05-08-2025
- Dividend Yield
- MLYS N/A
- SSYS N/A
- EPS Growth
- MLYS N/A
- SSYS N/A
- EPS
- MLYS N/A
- SSYS N/A
- Revenue
- MLYS N/A
- SSYS $564,454,000.00
- Revenue This Year
- MLYS N/A
- SSYS $1.78
- Revenue Next Year
- MLYS N/A
- SSYS $3.98
- P/E Ratio
- MLYS N/A
- SSYS N/A
- Revenue Growth
- MLYS N/A
- SSYS N/A
- 52 Week Low
- MLYS $8.24
- SSYS $6.05
- 52 Week High
- MLYS $18.38
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- MLYS 61.10
- SSYS 73.48
- Support Level
- MLYS $14.03
- SSYS $9.45
- Resistance Level
- MLYS $15.79
- SSYS $11.55
- Average True Range (ATR)
- MLYS 0.93
- SSYS 0.35
- MACD
- MLYS 0.16
- SSYS 0.22
- Stochastic Oscillator
- MLYS 92.27
- SSYS 87.55
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.